Contact l Sitemap

home industries issues reasearch weblog press

Home  » Issues » Regulation

Regulation

There are laws on the books worldwide that constrain the activity of corporations. The problem is enforcing them effectively, especially when the people who run the businesses can frequently persuade authorities to change the rules to suit them. We explore the role of government in setting and enforcing rules for fairness and competition in the private sector, and how the private sector manages to set the regulation agenda itself.


Drugs Tested By GVK Biosciences Banned From European Union
by Pratap ChatterjeeCorpWatch Blog
July 27th, 2015
Hundreds of drugs tested in India have been banned from sale in the European Union after French inspectors found flaws in clinical trials conducted by GVK Biosciences, a company based in Hyderabad. The Indian government has threatened to take legal action against the ban under international trade rules.

Subsidizing Contractor Misconduct: Alma's Story
by Chris ThompsonSpecial to CorpWatch
January 21st, 2015
When Alma Aranda tried to exercise her legal right to take unpaid time off to care for her dying mother, Verizon harassed her with so much paperwork that her hair fell out. In a new CorpWatch investigation into federal contractors who violate workers rights, Chris Thompson tells her story.

Subsidizing Contractor Misconduct
by Chris ThompsonSpecial to CorpWatch
January 7th, 2015
Every year, the U.S. government awards billions of dollars in federal contracts to companies who routinely violate basic legal rights of workers. This new report profiles three individuals who were harmed by Imperial Sugar, Tyson Foods and Verizon and explains a new presidential order that could help reduce abuses.

Uruguay Presents Defense Against Philip Morris Tobacco Lawsuit
by Richard SmallteacherCorpWatch Blog
November 10th, 2014
Uruguay has presented a 500 page document to defend itself against an international lawsuit challenging the country's tough tobacco packaging regulations. The claim was brought by Philip Morris, the global tobacco giant, at the World Bank's International Centre for Settlement of Investment Disputes (ICSID) in Washington DC.

New European Commission Marred By Corporate Conflicts of Interest
by Pratap ChatterjeeCorpWatch Blog
November 2nd, 2014
The newly elected president of the European Commission and his cabinet - who together form the central executive body for the 28 member states of the European Union - have deep ties with powerful corporate interests that make them poor choices to support citizen rights, say critics.

Argentina Loses Court Appeal Against “Vulture” Fund Manager Paul Singer
by Pratap ChatterjeeCorpWatch Blog
June 20th, 2014
Paul Singer, the billionaire hedge fund manager, has claimed victory in a lawsuit to force Argentina to fork out almost 17 times more than he paid to buy bonds issued by the country.

U.S. Congress Did Less for Corporate Accountability in 2013
by Corporate Accountability Coalition
June 4th, 2014
The U.S. Congress saw no progresses toward corporate accountability and reining in corporate influence over public institutions in 2013, according to the newly released Corporate Accountability Coalition (CAC) Congressional Report Card.

Toyota May Pay $1 Billion To Settle Unintentional Accelerations Claims
by Richard SmallteacherCorpWatch Blog
February 17th, 2014
Toyota is expected to announce a billion dollar settlement with the U.S. government for failing to disclose complaints by drivers that its cars were accelerating unintentionally. News of the negotiations were reported by the Wall Street Journal.

Anglo Irish Bankers On Trial For Scheme That Led to National Collapse
by Pratap ChatterjeeCorpWatch Blog
February 12th, 2014
Three top executives at Anglo Irish bank are on trial for a secret scheme to buy their own bank’s shares that eventually triggered the 2008 collapse of the Irish economy. The bankers allegedly hatched the plan to cover up bets made by Sean Quinn, once Ireland’s richest man.

Ranbaxy Pays $500 Million Fine for Selling Bad Batches of Generic Medicines
by Pratap ChatterjeeCorpWatch Blog
May 14th, 2013
Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has paid a $500 million fine and pled guilty to selling adulterated drugs manufactured in India. The settlement comes 16 months after the company signed an agreement with U.S. authorities to change its ways.

Displaying 1-10 of 43  
Next >> 
Last Page » 
« Show Complete List »